Koichiro Kuwahara Selected Research

Koichiro Kuwahara Research Topics

Disease

53	Heart Failure 04/2024 - 05/2003
17	Myocardial Infarction 04/2024 - 05/2003
10	Stroke (Strokes) 01/2024 - 01/2016
10	Cardiomegaly (Heart Hypertrophy) 12/2013 - 10/2003
9	Hypertrophy 12/2013 - 02/2002
8	Fibrosis (Cirrhosis) 12/2016 - 10/2003
7	Coronary Artery Disease (Coronary Atherosclerosis) 01/2024 - 01/2017
6	Peripheral Arterial Disease 12/2022 - 11/2017
5	Cardiac Arrhythmias (Arrythmia) 04/2024 - 03/2006
5	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 03/2011
4	Diabetes Mellitus 11/2023 - 01/2020
4	Inflammation (Inflammations) 03/2023 - 01/2017
4	Chronic Limb-Threatening Ischemia 11/2022 - 01/2019
4	Atrial Fibrillation 07/2022 - 09/2017
4	Cardiomyopathies (Cardiomyopathy) 12/2019 - 05/2007
4	Sudden Death 01/2016 - 06/2009
4	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 10/2014 - 06/2009
3	Ventricular Tachycardia 01/2024 - 05/2013
3	Acute Coronary Syndrome 01/2023 - 02/2021
3	Hemorrhage 01/2023 - 01/2018
3	Ischemia 01/2023 - 01/2003
3	Chronic Renal Insufficiency 01/2022 - 01/2016
3	Left Ventricular Dysfunction 06/2017 - 11/2005
2	Renal Insufficiency (Renal Failure) 10/2023 - 08/2017
2	Ischemic Stroke 01/2023 - 11/2021
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2023 - 01/2003
2	Frailty 12/2022 - 12/2021
2	Anemia 11/2021 - 08/2021
2	Thrombosis (Thrombus) 07/2021 - 01/2019
2	Amyloidosis 01/2021 - 12/2019
2	Body Weight (Weight, Body) 01/2021 - 08/2009
2	Hypokalemia 07/2019 - 11/2016
2	Death (Near-Death Experience) 02/2019 - 10/2014
2	Atherosclerosis 01/2019 - 01/2017
2	Infarction (Infarctions) 11/2018 - 05/2003
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 02/2018 - 03/2006
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2017 - 01/2016
2	Hypertension (High Blood Pressure) 11/2016 - 05/2012
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2014 - 01/2012
2	Heart Diseases (Heart Disease) 01/2013 - 01/2010
1	Anorexia 04/2024
1	Malnutrition (Nutritional Deficiencies) 04/2024
1	Hyperkalemia 10/2023
1	Hypotension (Low Blood Pressure) 10/2023

Drug/Important Bio-Agent (IBA)

24	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023 - 02/2002
11	Atrial Natriuretic Factor (ANF)IBA 08/2022 - 10/2003
10	Angiotensin IIIBA 01/2020 - 05/2003
8	Natriuretic PeptidesIBA 01/2023 - 08/2005
7	omega-Chloroacetophenone (Mace)IBA 01/2024 - 01/2016
7	pro-brain natriuretic peptide (1-76)IBA 01/2023 - 01/2012
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2013
5	Type 1 Angiotensin ReceptorIBA 01/2016 - 03/2006
4	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2023 - 02/2019
4	Hemoglobins (Hemoglobin)IBA 01/2023 - 01/2016
4	AlbuminsIBA 07/2022 - 01/2017
4	Hormones (Hormone)IBA 02/2018 - 02/2002
4	RE1-silencing transcription factorIBA 05/2013 - 12/2006
3	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2005
3	SodiumIBA 11/2023 - 08/2005
3	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2023 - 01/2020
3	Serum AlbuminIBA 01/2023 - 01/2020
3	Anti-Bacterial Agents (Antibiotics)IBA 05/2022 - 10/2018
3	Transcription Factors (Transcription Factor)IBA 01/2019 - 12/2006
3	cilnidipineIBA 11/2018 - 10/2014
3	NitrendipineIBA 01/2016 - 09/2009
3	Messenger RNA (mRNA)IBA 09/2015 - 05/2003
3	Guanylate Cyclase-Coupled ReceptorsIBA 08/2009 - 10/2003
3	atrial natriuretic factor receptor AIBA 06/2009 - 02/2004
2	DiureticsIBA 04/2024 - 10/2022
2	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 01/2020
2	Sodium-Glucose Transport ProteinsIBA 10/2023 - 10/2020
2	AnticoagulantsIBA 01/2023 - 07/2022
2	CreatinineIBA 08/2021 - 01/2016
2	empagliflozinIBA 10/2020 - 01/2020
2	Mineralocorticoid Receptor AntagonistsIBA 10/2020 - 01/2019
2	CatecholaminesIBA 11/2019 - 10/2018
2	Hyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsIBA 07/2019 - 02/2007
2	Apolipoproteins E (ApoE)IBA 01/2019 - 11/2012
2	myocardinIBA 01/2019 - 07/2010
2	Antihypertensive Agents (Antihypertensives)IBA 11/2016 - 08/2009
2	Peptides (Polypeptides)IBA 01/2014 - 06/2013
2	CollagenIBA 07/2010 - 08/2009
2	TRPC6 Cation ChannelIBA 06/2010 - 12/2006
2	CalcineurinIBA 06/2010 - 12/2006
2	CytokinesIBA 11/2005 - 01/2005
1	esaxerenoneIBA 11/2023
1	Enalapril FDA LinkGeneric 10/2023
1	Neprilysin (Neutral Endopeptidase)IBA 10/2023
1	sacubitril and valsartan sodium hydrate drug combinationIBA 10/2023
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 10/2023
1	Dobutamine FDA LinkGeneric 10/2023

Therapy/Procedure

15	Therapeutics 04/2024 - 05/2012
7	Percutaneous Coronary Intervention 01/2024 - 11/2017
6	Surgical Amputation (Amputations) 12/2022 - 01/2018
4	Renal Dialysis (Hemodialysis) 07/2022 - 01/2014
3	Length of Stay 10/2023 - 01/2021
3	Catheter Ablation 02/2021 - 01/2019
2	Transplantation 04/2024 - 01/2020
2	Stents 07/2022 - 07/2021
1	Cesarean Section (Caesarean Section) 01/2024